Pricing Log in Create free account

Lunai Bioworks Inc. (LNAI) vs Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI)

Lunai Bioworks Inc. and Scinai Immunotherapeutics Ltd. Sponsored ADR are both Biotechnology companies. Lunai Bioworks Inc. is the larger, with a market value of $830.0K against $320.0K — 2.6× the size. Lunai Bioworks Inc. has negative trailing earnings, so its P/E is not meaningful; Scinai Immunotherapeutics Ltd. Sponsored ADR trades at 0.0×. Scinai Immunotherapeutics Ltd. Sponsored ADR has the higher net margin (0.00% vs −3,761.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Scinai Immunotherapeutics Ltd. Sponsored ADR leads on 7 and Lunai Bioworks Inc. on 5.

Valuation

Metric LNAI SCNI Biotechnology median
P/E n/m 0.01 10.60
P/S 5.68 n/m 9.40
P/B n/m 0.03 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.29 0.66
EV/Sales 0.25 n/m 9.02
Earnings yield (640.81%) 18,535.67% (32.88%)
Free cash flow yield (988.00%) (3,801.33%) (23.13%)

Profitability

Metric LNAI SCNI Biotechnology median
Gross margin (3.48%) 0.00% 68.51%
Operating margin (9,184.79%) 0.00% 0.00%
Net margin (3,761.88%) 0.00% 0.00%
Free cash flow margin (5,610.24%) 0.00% 0.00%
Return on equity 23.46% 0.00% (51.96%)
Return on assets (39.21%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LNAI SCNI Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 98.77% (159.83%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LNAI SCNI Biotechnology median
Debt to equity 0.00 0.02 0.00
Current ratio 0.11 1.56 4.97
Net debt to EBITDA 0.20 0.25 1.01

Dividend

Metric LNAI SCNI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LNAI SCNI Biotechnology median
Market cap 830.00k 320.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack